Literature DB >> 7968365

Expression of Thy-1/lacZ fusion genes in the CNS of transgenic mice.

K A Kelley1, V L Friedrich, A Sonshine, Y Hu, J Lax, J Li, D Drinkwater, H Dressler, K Herrup.   

Abstract

Thy-1 is a cell surface glycoprotein of unknown function that is found on nerve cells and mature T-lymphocytes. To study the regulation of Thy-1 gene expression, mouse Thy-1.2 genomic sequences were joined to various marker sequences and the resulting chimeric constructs were used to produce nearly three dozen independent lines of transgenic mice. The starting point for our studies was an 8.2 kb EcoRI fragment that begins 1.7 kb 5' to the transcription start site and ends with 1.3 kb of 3' flanking sequences. Addition of a small marker oligonucleotide to the 3' untranslated region of this fragment had little or no effect on gene regulation. All of the lines derived from injection of this construct expressed the transgene in the appropriate tissues. Thus, as expected, the Thy-1.2 genomic fragment contains all of the information necessary for tissue-specific, position-independent expression of the modified transgene. Unexpectedly, Thy-1/lacZ hybrid genes did not mimic this behavior. Using either mRNA or histochemical detection of lacZ protein, these constructs were expressed in patterns that varied dramatically from line to line. This behavior suggests that integration site-specific effects dominate the cis-active Thy-1 regulatory elements leading to wide variability of expression. This is further emphasized by the observation that the bacterial reporter protein was found in a few non-neuronal cell-types, in contrast to the known pattern of native Thy-1 expression. These results suggest that either the Thy-1.2 sequences which are necessary for appropriate brain-specific expression are not contained solely within the proposed CNS enhancer in the first intron, or that fusion of the Thy-1.2 sequences with the lacZ coding region may disrupt normal Thy-1 regulatory signals (or result in the creation of new regulatory elements).

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7968365     DOI: 10.1016/0169-328x(94)90139-2

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  6 in total

1.  Expression of human apolipoprotein E4 in neurons causes hyperphosphorylation of protein tau in the brains of transgenic mice.

Authors:  I Tesseur; J Van Dorpe; K Spittaels; C Van den Haute; D Moechars; F Van Leuven
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

2.  Genomic sequences of aldolase C (Zebrin II) direct lacZ expression exclusively in non-neuronal cells of transgenic mice.

Authors:  E U Walther; M Dichgans; S M Maricich; R R Romito; F Yang; S Dziennis; S Zackson; R Hawkes; K Herrup
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-03       Impact factor: 11.205

3.  Enhanced hippocampal long-term potentiation and learning by increased neuronal expression of tissue-type plasminogen activator in transgenic mice.

Authors:  R Madani; S Hulo; N Toni; H Madani; T Steimer; D Muller; J D Vassalli
Journal:  EMBO J       Date:  1999-06-01       Impact factor: 11.598

Review 4.  Retinal Ganglion Cell Replacement: Current Status and Challenges Ahead.

Authors:  Adam M Miltner; Anna La Torre
Journal:  Dev Dyn       Date:  2018-10-11       Impact factor: 3.780

5.  Binary recombinase systems for high-resolution conditional mutagenesis.

Authors:  Mario Hermann; Patrick Stillhard; Hendrik Wildner; Davide Seruggia; Viktor Kapp; Héctor Sánchez-Iranzo; Nadia Mercader; Lluís Montoliu; Hanns Ulrich Zeilhofer; Pawel Pelczar
Journal:  Nucleic Acids Res       Date:  2014-01-09       Impact factor: 16.971

6.  Visual properties of transgenic rats harboring the channelrhodopsin-2 gene regulated by the thy-1.2 promoter.

Authors:  Hiroshi Tomita; Eriko Sugano; Yugo Fukazawa; Hitomi Isago; Yuka Sugiyama; Teru Hiroi; Toru Ishizuka; Hajime Mushiake; Megumi Kato; Masumi Hirabayashi; Ryuichi Shigemoto; Hiromu Yawo; Makoto Tamai
Journal:  PLoS One       Date:  2009-11-05       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.